UNOFFICIAL TRANSLATION
The formal official document is in Japanese
Summary of Consolidated Financial Results
for the Fiscal Year ended September 30, 2023 (Japanese Accounting Standards)
November 8, 2023 | ||||||||
Listed Company Name: MTI Ltd. | Listing Exchanges: Tokyo Stock Exchange | |||||||
Securities Code: | 9438 | URL:https://ir.mti.co.jp/eng/ | ||||||
Representative: | Toshihiro Maeta, President and Chief Executive Officer | |||||||
Contact: | Hiroshi Matsumoto, Senior managing Director | Phone: +81-3-5333-6323 | ||||||
Scheduled date of annual meeting of shareholders: December 23, 2023 | ||||||||
Scheduled date to submit the Securities Report (Yuka Shoken Houkokusho): December 25, 2023 | ||||||||
Scheduled date of dividend payment: December 25, 2023 | ||||||||
Supplementary documents for financial results: Yes | ||||||||
Financial results briefing: Yes (for securities analysts and institutional investors (On-demand)) | ||||||||
(Figures less than one millions of yen are omitted) | ||||||||
1. Consolidated financial results for the year ended September 30, 2023 | ||||||||
(October 1, 2022 - September 30, 2023) | ||||||||
(1) Consolidated operating results | (Percentages represent year-on-year changes) | |||||||
Net sales | Operating income | Ordinary income | Profit attributable to | |||||
owners of parent | ||||||||
Millions of yen | % Millions of yen | % Millions of yen | % Millions of yen | % | ||||
For the year ended September 30, 2023 | 26,798 | 1.2 | 298 | (65.7) | 458 | (5.7) | 753 | - |
For the year ended September 30, 2022 | 26,479 | 2.9 | 870 | (54.9) | 485 | (64.5) | (930) | - |
(Note) Comprehensive income: | Year ended September 30, 2023: 778 million yen, (-%) | |||||
Year months ended September 30, 2022: (1,137) million yen, (-%) | ||||||
Net income | Net income | Return on | Return on Assets | Net income | ||
per share | per share/diluted | Equity | ||||
Yen | Yen | % | % | % | ||
For the year ended September 30, 2023 | 13.73 | - | 5.4 | 1.6 | 1.1 | |
For the year ended September 30, 2022 | (16.99) | - | (5.9) | 1.6 | 3.3 | |
(Reference) Equity in earnings (losses) of affiliates: Year ended September 30 2023: 102 millions of yen | ||||||
Year ended September 30 2022: (457) millions of yen |
(2) Consolidated financial position
Total assets | Net assets | Equity ratio | Net assets per share | |
Millions of yen | Millions of yen | % | Yen | |
Year ended September 30, 2023 | 29,155 | 17,583 | 47.9 | 254.36 |
Year ended September 30, 2022 | 29,265 | 17,877 | 48.1 | 256.61 |
(Reference) Shareholders' equity: | Year ended September 30, 2023: 13,953 millions of yen | |||
Year ended September 30, 2022: 14,065 millions of yen |
(3) Consolidated cash flows
Net cash provided | Net cash provided | Net cash provided by | Cash and cash | |
by (used in) | by (used in) | (used in) financing | ||
equivalent | ||||
operating activities | investing activities | activities | ||
Millions of yen | Millions of yen | Millions of yen | Millions of yen | |
For the year ended September 30, 2023 | 4,764 | (1,349) | (1,784) | 13,720 |
For the year ended September 30, 2022 | (1,393) | (2,460) | 343 | 12,097 |
2. Dividends
For the year ended September 30, 2022 For the year ended September 30, 2023
For the year ending September 30, 2024 (forecast)
Dividend per share
End of | End of | End of | Amount of | Dividend ratio | Dividends on | ||
dividends paid | equity | ||||||
first | second | third | Year end | Annual | (Consolidated) | ||
(Total) | (Consolidated) | ||||||
quarter | period | quarter | |||||
Yen | Yen | Yen | Yen | Yen | % | % | |
- | 8.00 | - | 8.00 | 16.00 | 880 | - | 5.6 |
- | 8.00 | - | 8.00 | 16.00 | 880 | 116.5 | 6.3 |
- | 8.00 | - | 8.00 | 16.00 | - |
3. Forecast for consolidated financial results for the fiscal year ending September 30, 2024 (October 1, 2023 - September 30, 2024)
(Percentages represent year-on-year changes) | |||||||||
Net sales | Operating income | Ordinary income | Profit attributable to | Net income | |||||
owners of parent | per share | ||||||||
Millions of | |||||||||
Millions of yen | % | Millions of yen | % | % | Millions of yen | % | Yen | ||
yen | |||||||||
For the first half | 13,000 | (4.5) | 200 | - | +6.9 | 50 | - | 0.91 | |
200 | |||||||||
Full year | 27,000 | +0.8 | 1,000 | +235.1 | 1,000 | +118.1 | 400 | (46.9) | 7.32 |
* Notes
(1) Important changes of subsidiaries during the term (changes in specified subsidiaries resulting in change in scope of
consolidation): Not applicable | Exception: - | ||
New: - | |||
(2) Changes in accounting policies and changes or restatement of accounting estimates | Not applicable | ||
(i) | Changes in accounting policies due to the modification in accounting methods: | ||
(ii) | Changes in accounting policies other than (i): | Not applicable | |
(iii) | Changes in accounting estimates: | Not applicable | |
(iv) | Restatement: | Not applicable |
- Number of outstanding shares (common shares)
- Number of outstanding shares at the end of period (including treasury shares):
(ii) | 9/23: 61,264,600 shares | 9/22: 61,263,000 shares |
Number of treasury shares at the end of period | 9/22: | 6,450,273 shares |
(iii) | 9/23: | 6,405,973 shares |
Average number of shares during the period | 9/22: | 54,781,561 shares |
9/23: | 54,839,609 shares |
(Reference) Summary of financial results
1. Nonconsolidated financial results for the year ended September 30, 2023 (From October 1, 2022 - September 30, 2023)
(1) Nonconsolidated operating results | (Percentages are shown as year-on-year changes) | |||||||||
Net sales | Operating income | Ordinary income | Net income | |||||||
For the year ended | Millions of yen | ( | % | Millions of yen | ( | % | Millions of yen | % | Millions of yen | % |
20,763 | 3.2) | 1,477 | 48.7) | 761 | 40.9) | 2,404 | - | |||
September 30, 2023 | ||||||||||
For the year ended | 21,445 | 3.6 | 2,879 | 18.0 | 1,289 | (43.6) | (3,524) | - | ||
September 30, 2022 | ( | |||||||||
Net income per | Fully diluted net | |||||||||
share | income per share | |||||||||
For the year ended | Yen | Yen | ||||||||
43.69 | - | |||||||||
September 30, 2023 | ||||||||||
For the year ended | (64.10) | - | ||||||||
September 30, 2022 | ||||||||||
- Nonconsolidatedfinancial position
Total assets | |
For the year ended | Millions of yen |
26,817 | |
September 30, 2023 | |
For the year ended | 25,048 |
September 30, 2022 | |
(Reference) Shareholders' equity
As of September 30, 2023: 16,490 millions of yen
Net assets | Equity ratio | Net assets per share |
Millions of yen | % | Yen |
16,549 | 61.5 | 299.51 |
15,043 | 59.6 | 271.45 |
As of September 30, 2022: | 14,932 millions of yen |
* Status of review
Financial results is out of audit.
* Cautionary statement with respect to forward-looking statements
The forward-looking statements included in this material are based on the Company's judgments, assumptions, and convictions based on information available to the Company at the time of publication of this document and may differ materially from actual results for a range of factors, including conditions of Japanese and overseas economies, changes in the situation of operations in Japan and overseas, and uncertainties and potential risks inherent in forward-looking statements. The risks and uncertainties include unforeseeable effects of future events. For the assumptions underlying the forecasts and other notice on the use of earnings forecasts, please refer to "(4) Future outlook" on page 4 in the accompanying material.
While the Company planned to hold an online briefing on earnings chiefly for securities analysts and institutional investors on Thursday, November 9, 2023, for original Japanese.
Accompanying materials - Contents
1. Overview of operating results.....……………….…………………………..………………. 2
(1) | Overview of operating results for the current fiscal year…………………….………. | 2 |
(2) | Overview of financial position for the current fiscal year…………………………..… | 3 |
(3) | Overview of cash flow for the current fiscal year….…………………………..……… | 3 |
- Future outlook………………………………………………………………………... 4
2. | Basic policy for the selection of accounting standard…………….………………………… | 4 | |
3. | Consolidated financial statements and important notes………….………………………… | 5 | |
(1) | Consolidated balance sheet…………………………………………………………... | 5 | |
(2) | Consolidated statement of income and comprehensive income……………………... | 7 | |
(3) | Consolidated statement of changes in shareholders' equity…………………………. | 9 |
- Consolidated statement of cash flows………………………………………………... 11
1
1. Overview of operating results
(1) Overview of operating results for the current fiscal year
The Group is actively engaged in the healthcare business and the school DX business, both of which are expected to expand in the future, in order to enhance its corporate value over the medium to long term.
During the current fiscal year under review, consolidated net sales stood at ¥26,798 million (up 1.2% year on year) and gross profit at ¥18,373 million (down 1.7 % year on year), attributable to an increase in cost of sales.
Operating income stood at ¥298 million (down 65.7 % year on year)) due to an increase in selling, general and administrative expenses due chiefly to a rise in advertising expenses.
Ordinary income stood at ¥458 million (down 5.7% year on year) chiefly due to a share of profit of entities accounted for using equity method of ¥102 million (compared to a share of loss of entities accounted for using equity method of ¥457 million in the previous year).
Profit attributable to owners of parent amounted to ¥753 million (a loss of ¥930 million in the previous fiscal year) as a result of a significant increase in extraordinary income due to consumption taxes refund and gain on change in equity and a substantial decrease in extraordinary losses compared from the previous fiscal year.
Consolidated operating results
(Period from October 1, 2022 to September 30, 2023)
Fiscal year ended | Fiscal year ended | Change | ||
September 30, 2023 | September 30, 2022 | Amount | Percentage | |
Millions of yen | Millions of yen | Millions of yen | % | |
Net sales | 26,798 | 26,479 | +319 | +1.2 |
Cost of sales | 8,425 | 7,787 | +638 | +8.2 |
Gross profit | 18,373 | 18,691 | (318) | (1.7) |
SG&A | 18,074 | 17,820 | +253 | +1.4 |
Operating income | 298 | 870 | (572) | (65.7) |
Ordinary income | 458 | 485 | (27) | (5.7) |
Profit attributable to | 753 | (930) | +1,683 | - |
Owners of parent | ||||
Breakdown of SG&A
(Period from October 1, 2022 to September 30, 2023)
Fiscal year ended | Fiscal year ended | Change | ||
September 30, 2023 | September 30, 2022 | Amount | Percentage | |
Millions of yen | Millions of yen | Millions of yen | % | |
Total | 18,074 | 17,820 | +253 | +1.4 |
Advertising expenses | 2,136 | 1,580 | +555 | +35.2 |
Personnel expenses | 7,714 | 7,718 | (4) | (0.1) |
Commission fee | 2,954 | 3,094 | (139) | (4.5) |
Subcontract expenses | 1,965 | 2,136 | (171) | (8.0) |
Depreciation | 1,265 | 1,352 | (86) | (6.4) |
Other | 2,038 | 1,937 | +100 | +5.2 |
Operating results by segment are as follows.
Effective from the first quarter of the consolidated fiscal year under review, the classification of reportable segments has been revised. Comparison and analysis for the current fiscal year under review are based on the new segments.
- Content business
The content business includes B2C monthly billing services (excluding the "Luna-Luna" healthcare service for women and the "CARADA medica" health Q&A service in cooperation with healthcare professionals) and the B2B original comic distribution business that offers original comic content to comic distributors.
This segment served 3.13 million of paying subscribers. The figure was 70 thousand smaller than at the end of September 2022. The number of paying subscribers was nearly level, reflecting an increase in the number of
2
paying subscribers to the "AdGuard" security-related app.
Net sales totaled ¥18,108 million (down 2.2% year on year) due to a year-on-year decrease in the number of paying subscribers, which more than offset the video sales at Video Market Corporation, a consolidated subsidiary of the Company.
Operating income was ¥5,224 million (down 15.7% year-on-year) due to an increase in SG&A expenses resulting from a rise in advertising expenses to promote "AdGuard" membership.
- Healthcare business
The healthcare business includes B2C monthly billing services under the "Luna-Luna" and "CARADA medica" brands and B2B and B2B2C healthcare services for medical institutions and local governments, such as the cloud drug record service, the maternal health record book app and the childcare DX service.
This segment served 550 thousand of paying subscribers. The figure was 40 thousand smaller than at the end of September 2022. On the other hand, the number of pharmacies that offer the cloud drug record service came to 1,793 at the end of September 2023 (up 529 from the end of September 2022), as the result of great efforts focused on increasing the number of pharmacies whose motivation to introduce such service is growing.
Net sales came to ¥4,616 million (up 14.6% year on year), given expanded sales of Cloud drug record service and Childcare DX service, etc. The operating loss reduced to ¥224 million (loss of ¥1,108 million in the previous fiscal year) due to the effect of increased sales and implemented cost containment measures.
- School DX business
The school DX business includes school DX business developed for educational institutions by the consolidated subsidiary Motivation Works Inc.
Net sales amounted to ¥852 million (up 100.0% year on year) due to an increase in monthly usage fees from educational institutions that have introduced the "BLEND" cloud-based school business support system. "BLEND" has been used by 566 educational institutions since April 2023 (226 institutions more than a year ago). Operating loss was ¥668 million (loss of ¥841 million in the previous fiscal year) as a result of a decrease in deficit due to a significant increase in sales.
- Other business
Other business includes the B2B AI business operated by Automagi Inc., a consolidated subsidiary, and the Company's DX support business for large companies and solution business.
Sales decreased to ¥4,822 million (down 0.5% year on year) due to a fall in orders for the AI business, more than offsetting an increase in orders for corporate DX support business. The operating loss was ¥1,398 million (loss of ¥826 million in the previous year), primarily reflecting an increase in the cost of sales as a result of responses to projects in deficit in the corporate DX support business in addition to decreased sales in the AI business.
(2) Overview of financial position for the current fiscal year
As of the end of the fiscal year under review, total assets decreased ¥110 million from the end of September 2022, to ¥29,155 million.
Current assets increased ¥161 million mainly due to an increase in cash and deposits despite a decrease in consumption taxes refund receivable. Non-current assets declined ¥272 million chiefly due to a decrease in goodwill and customer-related assets, which more than offset an increase in investment securities.
Current liabilities increased ¥944 million, mainly reflecting rises in income taxes payable and contract liabilities. Non-current liabilities fell ¥760 million chiefly due to a decline in long-term borrowings.
Net assets decreased ¥293 million chiefly due dividend payments, despite a profit attributable to owners of parent of ¥753 million.
(3) Overview of cash flow position for the current fiscal year
As of the end of the fiscal year under review, cash and cash equivalents amounted to ¥13,720 million, an increase of ¥1,623 million from September 30, 2022. Cash flow by activity and principal factors in the fiscal year under review were as follows.
Net cash provided by operating activities stood at ¥4,764 million (net cash used of ¥1,393 million in the previous fiscal year), reflecting primarily profit before income taxes posted and reception of depreciation and consumption taxes refund receivable.
Net cash used in investing activities stood at ¥1,349 million (outflow of ¥2,460 million in the previous fiscal year). Principal factors included the acquisition of intangible assets (mainly purchase of software).
Net cash used in financing activities amounted to ¥1,784 million (net cash provided of ¥343 million in the previous fiscal year), which was attributable principally to repayment of long-term borrowings and dividends paid.
3
(4) Future outlook
The Company will work hard to expand sales and turn a profit in the healthcare business, which is expected to be a driving force for future performance growth. In the content business, it will make every effort to increase the number of paying subscribers by expanding sales of the "AdGuard" security-related app and striving to bolster the original comic distribution business.
Also, the Group will focus on expanding the school DX business that Motivation Works Inc., a subsidiary of the Company, is actively working to develop. Given the large number of business inquiries related to "BLEND", the cloud-based school affairs support system provided by Motivation Works, the Group is earnestly working to increase the number of schools that will introduce this system beginning in April 2024.
The Company takes medium- and long-term perspectives in its engagement in the healthcare business, which has strong potential for future growth and compared with B2C transactions, may move toward a more stable stock-type business through the establishment of long-term business relationships with customers. Therefore, the Company is committed to implementing a variety of measures to achieve sales growth.
The cloud drug record service is particularly in high demand in dispensing pharmacies and we will increase the number of introducing stores through enhancing cooperation with Medipal Holdings, our business partner. This is because it can contribute to the sustained growth of sales in the healthcare business.
It will also enhance childcare-related services with a focus on local governments that have introduced the "Boshimo", a maternal health record book app, and will advance digital cooperation among local governments, hospitals, and residents, thereby advancing its "Boshimo" childcare DX platform strategy to enable the healthcare business to make a contribution to profit in the medium term.
[Assumptions for forecast values]
The impact of undetermined new businesses and low-probability mergers and acquisitions in the Group are not taken into account and are not incorporated in the forecast figures. The Company will promptly disclose any deviation between forecasts and results that should be disclosed.
Earnings forecast for the six months of the fiscal year ending September 30, 2024 (Period from October 1, 2023 toMarch 30, 2024)
Consolidated | (Millions of yen) | YoY(%) |
Net sales | 13,000 | (4.5) |
Operating profit | 200 | (loss of ¥18 million in the |
previous fiscal year) | ||
Ordinary profit | 200 | +6.9 |
Profit attributable to | 50 | (loss of ¥326 million in the |
owners of parent | previous fiscal year) | |
Earnings forecast for the fiscal year ending September 30, 2024
(Period from October 1, 2023 to September 30, 2024)
Consolidated | (Millions of yen) | YoY(%) |
Net sales | 27,000 | +0.8 |
Operating profit | 1,000 | +235.1 |
Ordinary profit | 1,000 | +118.1 |
Profit attributable to | 400 | (46.9) |
owners of parent | ||
2. Basic policy for the selection of accounting standards
The Group intends to compile its consolidated financial statements based on the Japanese accounting standard for the time being, considering the possibility of comparing the terms of financial statements and performances between companies.
It will adopt the International Financial Reporting Standards (IFRS), factoring in the situations in Japan and abroad.
4
3.Consolidated financial statements and important notes
(1) Consolidated balance sheet
(Unit: thousands of yen) | ||
Previous fiscal year | Current fiscal year | |
(As of September 30, 2022) | (As of September 30, 2023) | |
Assets | ||
Current assets | ||
Cash and deposits | 12,097,658 | 13,720,915 |
Notes and accounts receivable - trade, and contract | 4,294,825 | 4,197,136 |
assets | ||
Advance payments-trade | 230,049 | 214,194 |
Prepaid expenses | 434,784 | 414,268 |
Accounts receivable-other | 71,031 | 131,853 |
Income taxes receivable | 485,089 | 10,630 |
Other | 1,199,240 | 285,346 |
Allowance for doubtful accounts | (34,097) | (33,941) |
Total current assets | 18,778,582 | 18,940,404 |
Non-current assets | ||
Property, plant and equipment | ||
Facilities attached to buildings | 308,888 | 328,982 |
Accumulated depreciation | (242,130) | (243,495) |
Facilities attached to buildings, net | 66,758 | 85,487 |
Vehicles | 277 | 478 |
Accumulated depreciation | (277) | (333) |
Vehicles, net | 0 | 144 |
Tools, furniture, and fixtures | 601,076 | 625,599 |
Accumulated depreciation | (474,773) | (497,520) |
Tools, furniture and fixtures, net | 126,302 | 128,079 |
Total property, plant and equipment | 193,060 | 213,711 |
Intangible assets | ||
Software | 2,058,982 | 1,894,135 |
Goodwill | 655,709 | 240,012 |
Customer-related assets | 912,600 | 491,400 |
Other | 163,473 | 230,614 |
Total intangible assets | 3,790,765 | 2,856,162 |
Investments and other assets | ||
Investment securities | 3,675,499 | 4,081,380 |
Lease and guarantee deposits | 337,475 | 305,268 |
Deferred tax assets | 2,394,793 | 2,658,854 |
Other | 106,411 | 110,361 |
Allowance for doubtful accounts | (10,904) | (10,704) |
Total investments and other assets | 6,503,275 | 7,145,160 |
Total non-current assets | 10,487,102 | 10,215,035 |
Total assets | 29,265,684 | 29,155,439 |
5
(Unit: thousands of yen) | ||
Previous fiscal year | Current fiscal year | |
(As of September 30, 2022) | (As of September 30, 2023) | |
Liabilities | ||
Current liabilities | ||
Accounts payable-trade | 1,068,638 | 1,023,077 |
Current portion of long-term loans payable | 751,780 | 747,600 |
Accounts payable-other | 1,221,218 | 1,279,759 |
Accrued expenses | 501,487 | 502,655 |
Income taxes payable | 19,236 | 637,619 |
Accrued consumption taxes | 23,161 | 316,185 |
Contract liabilities | 2,356,643 | 2,567,914 |
Provision for directors' bonuses | 30,609 | 28,862 |
Other | 413,577 | 227,086 |
Total current liabilities | 6,386,353 | 7,330,762 |
Non-current liabilities | ||
Long-term loans payable | 3,178,010 | 2,431,250 |
Net defined benefit liability | 1,816,159 | 1,786,153 |
Other | 7,432 | 23,449 |
Total non-current liabilities | 5,001,601 | 4,240,853 |
Total liabilities | 11,387,955 | 11,571,615 |
Net assets | ||
Shareholders' equity | ||
Capital stock | 5,218,512 | 5,232,677 |
Capital surplus | 6,768,841 | 6,485,816 |
Retained earnings | 5,224,287 | 5,143,458 |
Treasury shares | (3,257,237) | (3,230,813) |
Total shareholders' equity | 13,954,404 | 13,631,139 |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities | 75,554 | 165,132 |
Foreign currency translation adjustment | 89,490 | 97,848 |
Remeasurements of defined benefit plans | (53,931) | 59,594 |
Total accumulated other comprehensive income | 111,114 | 322,575 |
Subscription rights to shares | 110,774 | 59,147 |
Non-controlling interests | 3,701,436 | 3,570,962 |
Total net assets | 17,877,729 | 17,583,824 |
Total liabilities and net assets | 29,265,684 | 29,155,439 |
6
(2) Consolidated statement of income and consolidated comprehensive income Consolidated statement of income
(Unit: thousands of yen) | ||
Previous fiscal year | Current fiscal year | |
(from October 1, 2021 | (from October 1, 2022 | |
to September 30, 2022) | to September 30, 2023) | |
Net sales | 26,479,310 | 26,798,991 |
Cost of sales | 7,787,727 | 8,425,737 |
Gross profits | 18,691,583 | 18,373,254 |
Selling, general and administrative expenses | 17,820,953 | 18,074,827 |
Operating income | 870,629 | 298,426 |
Non-operating income | ||
Interest income | 135 | 104 |
Dividend income | 7,012 | 3,961 |
Foreign exchange gains | 102,308 | 38,170 |
Share of profit of entities accounted for using equity method | - | 102,204 |
Compensation income | 503 | 34,759 |
Other | 37,819 | 29,395 |
Total non-operating income | 147,777 | 208,596 |
Non-operating expenses | ||
Interest expenses | 5,491 | 11,489 |
Share of loss of entities accounted for using equity method | 457,088 | - |
Consumption tax difference | 17,018 | 22,562 |
Commission expenses | 9,231 | 7,903 |
Other | 43,621 | 6,615 |
Total non-operating expenses | 532,451 | 48,571 |
Ordinary income | 485,955 | 458,451 |
Extraordinary income | ||
Gain on sale of non-current assets | - | 501 |
Gain on sales of investment securities | - | 14 |
Gain on sale of shares of subsidiaries and associates | 12,417 | 19,904 |
Gain on change in equity | 76,481 | 237,588 |
Gain on reversal of share acquisition rights | 54,027 | 51,424 |
Consumption taxes refund | - | 873,339 |
Total extraordinary income | 142,925 | 1,182,773 |
Extraordinary losses | ||
Loss on sales of non-current assets | 119 | - |
Loss on retirement of non-current assets | 27,816 | 25,691 |
Impairment loss | 897,949 | 347,842 |
Loss on sale of investment securities | 3,240 | 13,450 |
Loss on valuation of investment securities | - | 55,689 |
Loss on step acquisitions | 4,700 | - |
Total extraordinary losses | 933,826 | 442,673 |
Profit (loss) before income taxes | (304,944) | 1,198,550 |
Income taxes - current | 718,258 | 947,796 |
Income taxes-deferred | 40,756 | (316,777) |
Total income taxes | 759,015 | 631,019 |
Profit (loss) | (1,063,960) | 567,530 |
Profit (loss) attributable to non-controlling interests | (133,485) | (185,689) |
Profit (loss) attributable to owners of parent | (930,474) | 753,220 |
7
Consolidated statement of comprehensive income
Profit (loss)
Other comprehensive income
Valuation difference on available-for-sale securities Foreign currency translation adjustment
Remeasurements of defined benefit plans, net of tax
Share of other comprehensive income of entities accounted for using equity method
Total other comprehensive income Comprehensive income (Comprehensive income attributable to)
Comprehensive income attributable to owners of parent
Comprehensive income attributable to non-controlling interests
(Unit: thousands of yen) | |
Previous fiscal year | Current fiscal year |
(from October 1, 2021 | (from October 1, 2022 |
to September 30, 2022) | to September 30, 2023) |
(1,063,960) | 567,530 |
(89,830) | 5,191 |
82,773 | 4,520 |
(67,810) | 113,525 |
1,597 | 88,224 |
(73,270) | 211,461 |
(1,137,230) | 778,992 |
(1,004,354) | 964,681 |
(132,876) | (185,689) |
8
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
MTI Ltd. published this content on 13 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2023 13:48:56 UTC.